Both in Pharmaceuticals
Rapport Therapeutics vs Syndax Pharmaceuticals
Over the past year RAPP returned +18.1% and SNDX returned +17.2%; their daily moves had a correlation of 0.33.
RAPP +18.1% SNDX +17.2%Growth of $1, one year, split-adjusted
| Metric | RAPP | SNDX |
|---|---|---|
| Price | $33.02 | $18.24 |
| Market cap | $1.58B | $1.63B |
| Today | −1.26% | +2.10% |
| 1 month | −32.3% | −6.7% |
| 6 months | +19.2% | −18.9% |
| Year to date | +8.8% | −13.2% |
| 1 year | +24.2% | +16.3% |
| Revenue growth (YoY) | — | +91.8% |
| Gross margin | — | 95.6% |
| Net margin | — | −67.8% |
| P/E (TTM) | — | — |
| Price / sales | 79.2× | 6.5× |
| Net cash | $436.1M | -$41.0M |
| Dividend yield | — | — |
| Volatility (60d) | 61.9% | 44.1% |
| Short % of float | 8.0% | 24.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).